[
  {
    "ts": "2026-02-10T00:12:00+00:00",
    "headline": "2 Intriguing Medical Stocks to Watch as Q4 Results Approach: EXEL, GILD",
    "summary": "With their Q4 results approaching after-market hours on Tuesday, February 10, Exelixis (EXEL) and Gilead Sciences (GILD) are two top-performing medical stocks to consider.",
    "url": "https://finance.yahoo.com/news/2-intriguing-medical-stocks-watch-001200311.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a278075c-271f-35d7-8269-bfbdc4fce4b3",
      "content": {
        "id": "a278075c-271f-35d7-8269-bfbdc4fce4b3",
        "contentType": "STORY",
        "title": "2 Intriguing Medical Stocks to Watch as Q4 Results Approach: EXEL, GILD",
        "description": "",
        "summary": "With their Q4 results approaching after-market hours on Tuesday, February 10, Exelixis (EXEL) and Gilead Sciences (GILD) are two top-performing medical stocks to consider.",
        "pubDate": "2026-02-10T00:12:00Z",
        "displayTime": "2026-02-10T00:12:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/737ffb82e07dc8bffb77e72d153c91f2",
          "originalWidth": 900,
          "originalHeight": 469,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FhE.FTVPiyZE7qpXxRqaxQ--~B/aD00Njk7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/737ffb82e07dc8bffb77e72d153c91f2.cf.webp",
              "width": 900,
              "height": 469,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sFRv_ZJmMJVPU2zxJKrzAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/737ffb82e07dc8bffb77e72d153c91f2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/2-intriguing-medical-stocks-watch-001200311.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-intriguing-medical-stocks-watch-001200311.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EXEL"
            },
            {
              "symbol": "BAYZF"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "BAYRY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T08:14:29+00:00",
    "headline": "Cisco Earnings, Jobs Report, CPI Data: What to Watch This Week",
    "summary": "This week brings a deluge of economic indicators, particularly jobs and inflation reports, which were stalled by the recent government shutdown. Investors will also navigate earnings reports and appearances by Federal Reserve policymakers.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-10-2026/card/cisco-earnings-jobs-report-cpi-data-what-to-watch-this-week-nIlxV4YAKF0p3Iuftmhc?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "8963887f-752e-32c2-9bcf-9778594885b7",
      "content": {
        "id": "8963887f-752e-32c2-9bcf-9778594885b7",
        "contentType": "STORY",
        "title": "Cisco Earnings, Jobs Report, CPI Data: What to Watch This Week",
        "description": "",
        "summary": "This week brings a deluge of economic indicators, particularly jobs and inflation reports, which were stalled by the recent government shutdown. Investors will also navigate earnings reports and appearances by Federal Reserve policymakers.",
        "pubDate": "2026-02-10T08:14:29Z",
        "displayTime": "2026-02-10T08:14:29Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/8963887f-752e-32c2-9bcf-9778594885b7/cisco-earnings-jobs-report-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/05766f3173ada94d07d55c12d565fe11",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/74Y7puEtMTJo02esBmIMTg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/05766f3173ada94d07d55c12d565fe11.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ng98BxS_YdX7FknFQwiRaQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/05766f3173ada94d07d55c12d565fe11.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-10-2026/card/cisco-earnings-jobs-report-cpi-data-what-to-watch-this-week-nIlxV4YAKF0p3Iuftmhc?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CSCO"
            },
            {
              "symbol": "KO"
            },
            {
              "symbol": "MAR"
            },
            {
              "symbol": "F"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "MCD"
            },
            {
              "symbol": "KHC"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "TMUS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T11:09:56+00:00",
    "headline": "FDA Yescarta Decision Fuels Questions On Gilead Valuation And Momentum",
    "summary": "FDA removes prior limitations on Gilead Sciences' Yescarta for relapsed or refractory primary central nervous system lymphoma. Yescarta becomes the only CAR T cell therapy with this status for relapsed or refractory large B cell lymphoma. The decision broadens the eligible patient pool for a rare and difficult to treat lymphoma subtype. Gilead Sciences, NasdaqGS:GILD, is drawing fresh attention after the FDA cleared a wider path for its Yescarta cell therapy in challenging lymphoma cases...",
    "url": "https://finance.yahoo.com/news/fda-yescarta-decision-fuels-questions-110956214.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "36fa707d-2833-322b-bc8b-eacb86fe5d02",
      "content": {
        "id": "36fa707d-2833-322b-bc8b-eacb86fe5d02",
        "contentType": "STORY",
        "title": "FDA Yescarta Decision Fuels Questions On Gilead Valuation And Momentum",
        "description": "",
        "summary": "FDA removes prior limitations on Gilead Sciences' Yescarta for relapsed or refractory primary central nervous system lymphoma. Yescarta becomes the only CAR T cell therapy with this status for relapsed or refractory large B cell lymphoma. The decision broadens the eligible patient pool for a rare and difficult to treat lymphoma subtype. Gilead Sciences, NasdaqGS:GILD, is drawing fresh attention after the FDA cleared a wider path for its Yescarta cell therapy in challenging lymphoma cases...",
        "pubDate": "2026-02-10T11:09:56Z",
        "displayTime": "2026-02-10T11:09:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HAEiJmFsYXJTRBPxnneP6w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hXB9F2qU7k4qk3_k1DQd9A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-yescarta-decision-fuels-questions-110956214.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-yescarta-decision-fuels-questions-110956214.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T10:28:37+00:00",
    "headline": "Stocks to Watch Tuesday: Coca-Cola, Onsemi, Ford",
    "summary": "‚ÜòÔ∏è On Semiconductor (ON): The chip company missed quarterly revenue forecasts, with sales declining in its two biggest businesses. Shares dropped 4% in premarket trading. üîé Coca-Cola (KO), Marriott (MAR), Spotify (SPOT) and S&P Global (SPGI) are among the companies due to report results ahead of the open.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-10-2026/card/stocks-to-watch-tuesday-bp-onsemi-tsmc-eIVga3LDy4IZXYoKFYZV?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "a6618300-7bb0-377c-b641-fce96fef280b",
      "content": {
        "id": "a6618300-7bb0-377c-b641-fce96fef280b",
        "contentType": "STORY",
        "title": "Stocks to Watch Tuesday: Coca-Cola, Onsemi, Ford",
        "description": "",
        "summary": "‚ÜòÔ∏è On Semiconductor (ON): The chip company missed quarterly revenue forecasts, with sales declining in its two biggest businesses. Shares dropped 4% in premarket trading. üîé Coca-Cola (KO), Marriott (MAR), Spotify (SPOT) and S&P Global (SPGI) are among the companies due to report results ahead of the open.",
        "pubDate": "2026-02-10T10:28:37Z",
        "displayTime": "2026-02-10T10:28:37Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a6618300-7bb0-377c-b641-fce96fef280b/stocks-to-watch-tuesday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/1d3fe3ecd99e5024e987d7e4b243406c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/S8cuciQMktfCSYTg9A7YNA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/1d3fe3ecd99e5024e987d7e4b243406c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HKkxnen8w.kPQ_GgdjfErQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/1d3fe3ecd99e5024e987d7e4b243406c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-10-2026/card/stocks-to-watch-tuesday-bp-onsemi-tsmc-eIVga3LDy4IZXYoKFYZV?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ON"
            },
            {
              "symbol": "KO"
            },
            {
              "symbol": "F"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "MAR"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T12:40:07+00:00",
    "headline": "Stocks Rise Pre-Bell as Investors Await More Earnings, Retail Sales Report",
    "summary": "US equity futures were pointing higher on Tuesday as traders await the latest batch of corporate ear",
    "url": "https://finance.yahoo.com/news/stocks-rise-pre-bell-investors-124007484.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "d0785f08-6f18-3ea3-9674-ab7ea7c4546a",
      "content": {
        "id": "d0785f08-6f18-3ea3-9674-ab7ea7c4546a",
        "contentType": "STORY",
        "title": "Stocks Rise Pre-Bell as Investors Await More Earnings, Retail Sales Report",
        "description": "",
        "summary": "US equity futures were pointing higher on Tuesday as traders await the latest batch of corporate ear",
        "pubDate": "2026-02-10T12:40:07Z",
        "displayTime": "2026-02-10T12:40:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86",
          "originalWidth": 1024,
          "originalHeight": 683,
          "caption": "wall street stock market flag new york trading equity - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QVMgErJdOR7IkzCjRHm3pQ--~B/aD02ODM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86.cf.webp",
              "width": 1024,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dimQxOClk1isv1IKNf9JtA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/8685121785649cec3dbcdbbd25333a86.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stocks-rise-pre-bell-investors-124007484.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stocks-rise-pre-bell-investors-124007484.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "ON"
            },
            {
              "symbol": "SPGI"
            },
            {
              "symbol": "SPOT"
            },
            {
              "symbol": "CCO"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "F"
            },
            {
              "symbol": "KO"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "DDOG"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "MAR"
            },
            {
              "symbol": "DD"
            },
            {
              "symbol": "HAS"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "HOOD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T12:20:49+00:00",
    "headline": "Stocks to Watch Tuesday: Coca-Cola, Onsemi, Spotify",
    "summary": "‚ÜóÔ∏è Spotify (SPOT): The audio streamer's quarterly results topped forecasts, fueling a premarket rally in its shares. ‚ÜòÔ∏è On Semiconductor (ON): The chip company missed quarterly revenue forecasts, with sales declining in its two biggest businesses.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-10-2026/card/stocks-to-watch-tuesday-bp-onsemi-tsmc-eIVga3LDy4IZXYoKFYZV?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "a6618300-7bb0-377c-b641-fce96fef280b",
      "content": {
        "id": "a6618300-7bb0-377c-b641-fce96fef280b",
        "contentType": "STORY",
        "title": "Stocks to Watch Tuesday: Coca-Cola, Onsemi, Spotify",
        "description": "",
        "summary": "‚ÜóÔ∏è Spotify (SPOT): The audio streamer's quarterly results topped forecasts, fueling a premarket rally in its shares. ‚ÜòÔ∏è On Semiconductor (ON): The chip company missed quarterly revenue forecasts, with sales declining in its two biggest businesses.",
        "pubDate": "2026-02-10T12:20:49Z",
        "displayTime": "2026-02-10T12:20:49Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a6618300-7bb0-377c-b641-fce96fef280b/stocks-to-watch-tuesday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/1d3fe3ecd99e5024e987d7e4b243406c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/S8cuciQMktfCSYTg9A7YNA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/1d3fe3ecd99e5024e987d7e4b243406c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HKkxnen8w.kPQ_GgdjfErQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/1d3fe3ecd99e5024e987d7e4b243406c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-10-2026/card/stocks-to-watch-tuesday-bp-onsemi-tsmc-eIVga3LDy4IZXYoKFYZV?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KO"
            },
            {
              "symbol": "ON"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "F"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T19:07:16+00:00",
    "headline": "Earnings, Macro Data Leave Equity Markets Mixed Intraday",
    "summary": "US benchmark equity indexes were mixed intraday as traders evaluated the latest batch of corporate e",
    "url": "https://finance.yahoo.com/news/earnings-macro-data-leave-equity-190716062.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "20436673-52b1-3f6a-9fe1-ffcc6a423814",
      "content": {
        "id": "20436673-52b1-3f6a-9fe1-ffcc6a423814",
        "contentType": "STORY",
        "title": "Earnings, Macro Data Leave Equity Markets Mixed Intraday",
        "description": "",
        "summary": "US benchmark equity indexes were mixed intraday as traders evaluated the latest batch of corporate e",
        "pubDate": "2026-02-10T19:07:16Z",
        "displayTime": "2026-02-10T19:07:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a",
          "originalWidth": 1024,
          "originalHeight": 768,
          "caption": "Stocks_Chart market equity trading wall street - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0eWqzzTTIs4ZCQG0VOzLjA--~B/aD03Njg7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a.cf.webp",
              "width": 1024,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/woUn3cfJYPXMhxA4_4CCeg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/earnings-macro-data-leave-equity-190716062.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/earnings-macro-data-leave-equity-190716062.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "KO"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "DDOG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T21:51:00+00:00",
    "headline": "Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway.",
    "summary": "Less than two months into 2026, shares of  Gilead Sciences  are already outpacing some of the most talked-about pharmaceutical companies.  After the closing bell, the biopharmaceutical company posted adjusted earnings of $1.86 a share, which outstripped analysts‚Äô calls for $1.81.  Gilead attributed the change to higher sales of HIV and liver-disease products, which were partially offset by lower sales of Veklury, its Covid-19 antiviral.",
    "url": "https://www.barrons.com/articles/gilead-earnings-stock-price-f1f36bf5?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "8a748589-aea8-3e07-a0d3-cb4d585b2ae3",
      "content": {
        "id": "8a748589-aea8-3e07-a0d3-cb4d585b2ae3",
        "contentType": "STORY",
        "title": "Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway.",
        "description": "",
        "summary": "Less than two months into 2026, shares of  Gilead Sciences  are already outpacing some of the most talked-about pharmaceutical companies.  After the closing bell, the biopharmaceutical company posted adjusted earnings of $1.86 a share, which outstripped analysts‚Äô calls for $1.81.  Gilead attributed the change to higher sales of HIV and liver-disease products, which were partially offset by lower sales of Veklury, its Covid-19 antiviral.",
        "pubDate": "2026-02-10T21:51:00Z",
        "displayTime": "2026-02-10T21:51:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/8a748589-aea8-3e07-a0d3-cb4d585b2ae3/gilead-earnings-surprise-why.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/89f489d64b0a92a4a22fd03aa27f2b15",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/X078vvJXUIiLEBq8utnocA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/89f489d64b0a92a4a22fd03aa27f2b15.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cpMrX8Jl6P9ldyk1tq3_og--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/89f489d64b0a92a4a22fd03aa27f2b15.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/gilead-earnings-stock-price-f1f36bf5?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T21:17:20+00:00",
    "headline": "Gilead Sciences‚Äôs (NASDAQ:GILD) Q4 CY2025 Sales Beat Estimates",
    "summary": "Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported Q4 CY2025 results exceeding the market‚Äôs revenue expectations, with sales up 5.2% year on year to $7.93 billion. On the other hand, the company‚Äôs full-year revenue guidance of $29.8 billion at the midpoint came in 1.2% below analysts‚Äô estimates. Its non-GAAP profit of $1.86 per share was 1.9% above analysts‚Äô consensus estimates.",
    "url": "https://finance.yahoo.com/news/gilead-sciences-nasdaq-gild-q4-211720248.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "081d206e-bd47-3240-b3ea-45be87a24d69",
      "content": {
        "id": "081d206e-bd47-3240-b3ea-45be87a24d69",
        "contentType": "STORY",
        "title": "Gilead Sciences‚Äôs (NASDAQ:GILD) Q4 CY2025 Sales Beat Estimates",
        "description": "",
        "summary": "Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported Q4 CY2025 results exceeding the market‚Äôs revenue expectations, with sales up 5.2% year on year to $7.93 billion. On the other hand, the company‚Äôs full-year revenue guidance of $29.8 billion at the midpoint came in 1.2% below analysts‚Äô estimates. Its non-GAAP profit of $1.86 per share was 1.9% above analysts‚Äô consensus estimates.",
        "pubDate": "2026-02-10T21:17:20Z",
        "displayTime": "2026-02-10T21:17:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/0c2e68ead77a9450e1fb435ed236802c",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "GILD Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7IhZSScYZ4CvnQJJpve_Dg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/0c2e68ead77a9450e1fb435ed236802c.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cv.0mSrHV7hG2Zeh2xc10A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/0c2e68ead77a9450e1fb435ed236802c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-nasdaq-gild-q4-211720248.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-nasdaq-gild-q4-211720248.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T21:13:37+00:00",
    "headline": "Gilead: Q4 Earnings Snapshot",
    "summary": "On a per-share basis, the Foster City, California-based company said it had net income of $1.74. Earnings, adjusted for one-time gains and costs, came to $1.86 per share. The results topped Wall Street expectations.",
    "url": "https://finance.yahoo.com/news/gilead-q4-earnings-snapshot-211337558.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "0c203648-c4bb-32ec-a644-1d63e7179f1c",
      "content": {
        "id": "0c203648-c4bb-32ec-a644-1d63e7179f1c",
        "contentType": "STORY",
        "title": "Gilead: Q4 Earnings Snapshot",
        "description": "",
        "summary": "On a per-share basis, the Foster City, California-based company said it had net income of $1.74. Earnings, adjusted for one-time gains and costs, came to $1.86 per share. The results topped Wall Street expectations.",
        "pubDate": "2026-02-10T21:13:37Z",
        "displayTime": "2026-02-10T21:13:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-q4-earnings-snapshot-211337558.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-q4-earnings-snapshot-211337558.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T21:13:00+00:00",
    "headline": "Will Gilead's Solid Fourth Quarter Be Enough To Shake Off Its Light Outlook?",
    "summary": "Gilead Sciences cleanly beat fourth-quarter expectations late Tuesday, but Gilead stock took a hit on its light guidance for 2026.",
    "url": "https://www.investors.com/news/technology/gilead-stock-gilead-sciences-earnings-q4-2025/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "1b616d78-4f60-39cd-9f96-6ceb8e28749c",
      "content": {
        "id": "1b616d78-4f60-39cd-9f96-6ceb8e28749c",
        "contentType": "STORY",
        "title": "Will Gilead's Solid Fourth Quarter Be Enough To Shake Off Its Light Outlook?",
        "description": "",
        "summary": "Gilead Sciences cleanly beat fourth-quarter expectations late Tuesday, but Gilead stock took a hit on its light guidance for 2026.",
        "pubDate": "2026-02-10T21:13:00Z",
        "displayTime": "2026-02-10T21:13:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/1b616d78-4f60-39cd-9f96-6ceb8e28749c/will-gilead-s-solid-fourth.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/c41f2b75ef43110c88cfcb472262eb79",
          "originalWidth": 945,
          "originalHeight": 533,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/shVGxj7bu_u.CpYzNTXRdw--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/c41f2b75ef43110c88cfcb472262eb79.cf.webp",
              "width": 945,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WU5OlgKO09tNMial_TfFPA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/c41f2b75ef43110c88cfcb472262eb79.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/gilead-stock-gilead-sciences-earnings-q4-2025/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T21:02:00+00:00",
    "headline": "Gilead Sciences Announces 3.8 Percent Increase in First Quarter 2026 Dividend",
    "summary": "FOSTER CITY, Calif., February 10, 2026--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company‚Äôs Board of Directors has declared an increase of 3.8% in the company‚Äôs quarterly cash dividend, beginning in the first quarter of 2026. The increase will result in a quarterly dividend of $0.82 per share of common stock. The dividend is payable on March 30, 2026, to stockholders of record at the close of business on March 13, 2026. Future dividends will be subject to Board approval.",
    "url": "https://finance.yahoo.com/news/gilead-sciences-announces-3-8-210200700.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "86eadeff-2950-374e-868c-44249086c989",
      "content": {
        "id": "86eadeff-2950-374e-868c-44249086c989",
        "contentType": "STORY",
        "title": "Gilead Sciences Announces 3.8 Percent Increase in First Quarter 2026 Dividend",
        "description": "",
        "summary": "FOSTER CITY, Calif., February 10, 2026--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company‚Äôs Board of Directors has declared an increase of 3.8% in the company‚Äôs quarterly cash dividend, beginning in the first quarter of 2026. The increase will result in a quarterly dividend of $0.82 per share of common stock. The dividend is payable on March 30, 2026, to stockholders of record at the close of business on March 13, 2026. Future dividends will be subject to Board approval.",
        "pubDate": "2026-02-10T21:02:00Z",
        "displayTime": "2026-02-10T21:02:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/f41e44e2012f9bb86ae8166c62da75af",
          "originalWidth": 1728,
          "originalHeight": 576,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DwysmefBvUPAZGfxUDX0eg--~B/aD01NzY7dz0xNzI4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f41e44e2012f9bb86ae8166c62da75af.cf.webp",
              "width": 1728,
              "height": 576,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/q_rNB.l2BJwem2yRa0YFWQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f41e44e2012f9bb86ae8166c62da75af.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-announces-3-8-210200700.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-announces-3-8-210200700.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T21:01:00+00:00",
    "headline": "Gilead Sciences Announces Fourth Quarter and Full Year 2025 Financial Results",
    "summary": "FOSTER CITY, Calif., February 10, 2026--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2025.",
    "url": "https://finance.yahoo.com/news/gilead-sciences-announces-fourth-quarter-210100510.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "ccf2b32c-3e3b-3c1d-913c-eb4e816c9324",
      "content": {
        "id": "ccf2b32c-3e3b-3c1d-913c-eb4e816c9324",
        "contentType": "STORY",
        "title": "Gilead Sciences Announces Fourth Quarter and Full Year 2025 Financial Results",
        "description": "",
        "summary": "FOSTER CITY, Calif., February 10, 2026--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2025.",
        "pubDate": "2026-02-10T21:01:00Z",
        "displayTime": "2026-02-10T21:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/cb315f8fb6505716d741ddc2d68158c5",
          "originalWidth": 1728,
          "originalHeight": 576,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nEkwfV1eok2GUNQol0FbMw--~B/aD01NzY7dz0xNzI4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/cb315f8fb6505716d741ddc2d68158c5.cf.webp",
              "width": 1728,
              "height": 576,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Kzz4uJHmo8AKytVUhbAexA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/cb315f8fb6505716d741ddc2d68158c5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-announces-fourth-quarter-210100510.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-announces-fourth-quarter-210100510.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T17:37:08+00:00",
    "headline": "Stock Market Today, Feb: 10: Dow hits intraday record after retail sales disappoint",
    "summary": "This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Tuesday. This is TheStreet‚Äôs Stock Market Today for Feb. 10, 2025. You can follow the latest updates on the market ...",
    "url": "https://www.thestreet.com/latest-news/stock-market-today-feb-10-stocks-are-flat-after-retail-sales-are-unchanged-in-december",
    "source": "TheStreet",
    "provider": "yfinance",
    "raw": {
      "id": "d81a06f0-5b5b-3b6e-9368-2812c63d91d4",
      "content": {
        "id": "d81a06f0-5b5b-3b6e-9368-2812c63d91d4",
        "contentType": "STORY",
        "title": "Stock Market Today, Feb: 10: Dow hits intraday record after retail sales disappoint",
        "description": "",
        "summary": "This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Tuesday. This is TheStreet‚Äôs Stock Market Today for Feb. 10, 2025. You can follow the latest updates on the market ...",
        "pubDate": "2026-02-10T17:37:08Z",
        "displayTime": "2026-02-10T17:37:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/thestreet_881/8713643f17371ba19e611c944aede912",
          "originalWidth": 1200,
          "originalHeight": 800,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.ZyA7jB46lqhLkI73eDItg--~B/aD04MDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/thestreet_881/8713643f17371ba19e611c944aede912.cf.webp",
              "width": 1200,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wqytx4TqjdESh6.4KhbrfQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/thestreet_881/8713643f17371ba19e611c944aede912.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TheStreet",
          "url": "https://www.thestreet.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thestreet.com/latest-news/stock-market-today-feb-10-stocks-are-flat-after-retail-sales-are-unchanged-in-december",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stock-market-today-feb-10-173708850.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T23:19:07+00:00",
    "headline": "Gilead Sciences Q4 Earnings Call Highlights",
    "summary": "Gilead Sciences (NASDAQ:GILD) executives highlighted what they described as a ‚Äúremarkable year‚Äù of clinical, commercial, and operational execution in the company‚Äôs fourth-quarter and full-year 2025 earnings call, pointing to growth in HIV, momentum in liver disease and oncology, and a pipeline that",
    "url": "https://www.marketbeat.com/instant-alerts/gilead-sciences-q4-earnings-call-highlights-2026-02-10/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "d150f7c3-d091-3f39-93a6-be6e230a8db5",
      "content": {
        "id": "d150f7c3-d091-3f39-93a6-be6e230a8db5",
        "contentType": "STORY",
        "title": "Gilead Sciences Q4 Earnings Call Highlights",
        "description": "",
        "summary": "Gilead Sciences (NASDAQ:GILD) executives highlighted what they described as a ‚Äúremarkable year‚Äù of clinical, commercial, and operational execution in the company‚Äôs fourth-quarter and full-year 2025 earnings call, pointing to growth in HIV, momentum in liver disease and oncology, and a pipeline that",
        "pubDate": "2026-02-10T23:19:07Z",
        "displayTime": "2026-02-10T23:19:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/f4d50043a6ad9be86acba5b5bc857621",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Gilead Sciences logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nu9501bB9RGMHH4lni2oWg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/f4d50043a6ad9be86acba5b5bc857621.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tvsd1cTTJXDnPXRpt51NSw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/f4d50043a6ad9be86acba5b5bc857621.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/gilead-sciences-q4-earnings-call-highlights-2026-02-10/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-q4-earnings-call-231907950.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T23:05:11+00:00",
    "headline": "Gilead (GILD) Q4 2025 Earnings Call Transcript",
    "summary": "Daniel O'Day: Thank you, Jacquie, and good afternoon, everyone.  Starting with our full year results, our HIV business grew 6% year over year, driven by 7% growth in Biktarvy and 47% growth in our HIV prevention portfolio.  YES2GO, our twice-yearly HIV prevention injectable, has already exceeded our coverage goals and is rapidly gaining market share in addition to expanding the reach of HIV prevention to new users.",
    "url": "https://www.fool.com/earnings/call-transcripts/2026/02/10/gilead-gild-q4-2025-earnings-call-transcript/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "04acc84f-feb4-3690-8657-3fde51e9f195",
      "content": {
        "id": "04acc84f-feb4-3690-8657-3fde51e9f195",
        "contentType": "STORY",
        "title": "Gilead (GILD) Q4 2025 Earnings Call Transcript",
        "description": "",
        "summary": "Daniel O'Day: Thank you, Jacquie, and good afternoon, everyone.  Starting with our full year results, our HIV business grew 6% year over year, driven by 7% growth in Biktarvy and 47% growth in our HIV prevention portfolio.  YES2GO, our twice-yearly HIV prevention injectable, has already exceeded our coverage goals and is rapidly gaining market share in addition to expanding the reach of HIV prevention to new users.",
        "pubDate": "2026-02-10T23:05:11Z",
        "displayTime": "2026-02-10T23:05:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73",
          "originalWidth": 400,
          "originalHeight": 427,
          "caption": "Logo of jester cap with thought bubble.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V1aMxfEJkXDsPjicitZiIw--~B/aD00Mjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 400,
              "height": 427,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XzH.opsl71yJif6AsJGwPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/earnings/call-transcripts/2026/02/10/gilead-gild-q4-2025-earnings-call-transcript/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-gild-q4-2025-earnings-230511427.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T21:39:00+00:00",
    "headline": "Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products",
    "summary": "The biopharmaceutical company may start to offer two cancer therapies and an additional HIV treatment option this year.",
    "url": "https://www.wsj.com/tech/biotech/gilead-sciences-profit-rises-on-growth-of-liver-disease-hiv-products-b38ecc51?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "0b7e3e43-e956-3c72-9301-7d17a139635c",
      "content": {
        "id": "0b7e3e43-e956-3c72-9301-7d17a139635c",
        "contentType": "STORY",
        "title": "Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products",
        "description": "",
        "summary": "The biopharmaceutical company may start to offer two cancer therapies and an additional HIV treatment option this year.",
        "pubDate": "2026-02-10T21:39:00Z",
        "displayTime": "2026-02-10T21:39:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/0b7e3e43-e956-3c72-9301-7d17a139635c/gilead-sciences-profit-rises.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/6c6417271edcae9ab61154db5e078530",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ESZ_tH7eMNWE35tTAdv6rg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/6c6417271edcae9ab61154db5e078530.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ycZ4bTlf3txZjE6rIEY9Fg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/6c6417271edcae9ab61154db5e078530.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/tech/biotech/gilead-sciences-profit-rises-on-growth-of-liver-disease-hiv-products-b38ecc51?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]